MAIN ARTICLE
An outsider with a record of transformation
HP said its board unanimously selected Walmsley following a comprehensive global search. She ran GSK from April 2017 through December 2025, steering the drugmaker toward specialty medicines and vaccines, reshaping its research portfolio and overseeing the separation of its consumer-health business. Before joining GSK, she spent 17 years at L’Oréal. Those roles offer experience in global brands, customer relationships and organizations navigating major change, although they are far removed from the operational details of assembling and distributing computers.
Walmsley has never led a hardware manufacturer. She has, however, spent seven years on Microsoft's board, where the interaction between software, cloud computing and end-user devices is central to strategy. HP evidently sees cross-industry leadership as an asset rather than a barrier. Broussard, interim CEO since February, will replace Bergh as board chair on the day Walmsley takes office, providing continuity without keeping the interim management arrangement indefinitely.
Rising revenue does not mean rising volumes
HP's fiscal third-quarter numbers reveal a complicated recovery. Group revenue increased 12.5% to approximately $15.7 billion. Personal Systems revenue climbed 18% to $11.8 billion, but total PC unit shipments declined 16%.

















